Sanofi taps BioClinica for CTMS software; Amgen gets nod for tech in trials;

> Sanofi ($SNY) selected BioClinica's ($BIOC) clinical trial management system (CTMS) called OnPoint. Release

> The Institute of Cancer Research, London, has begun using U.K. software company Dotmatics' data visualization and analytics tool called Vortex for cancer drug R&D. Release

> Biopharma giant Amgen ($AMGN) won kudos for its use of software in managing aspects of clinical trials. Article

> Reuters notes some signs of life in the biotech venture capital scene. Item

> Xconomy's Luke Timmerman lists those in biotech you should follow on Twitter. Column

And Finally… Snake-arm robots offer the next generation of minimally invasive surgical tools. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.